189 related articles for article (PubMed ID: 6428366)
1. [Effects of potassium on renin and aldosterone].
Kotchen TA
Arch Mal Coeur Vaiss; 1984 Apr; 77 Spec No():87-91. PubMed ID: 6428366
[TBL] [Abstract][Full Text] [Related]
2. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].
Beretta-Piccoli C; Weidmann P; de Châtel R; Hirsch D; Reubi FC
Schweiz Med Wochenschr; 1977 Jan; 107(4):104-15. PubMed ID: 834983
[TBL] [Abstract][Full Text] [Related]
3. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
Hood SJ; Taylor KP; Ashby MJ; Brown MJ
Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
[TBL] [Abstract][Full Text] [Related]
4. The influence of potassium administration and of potassium deprivation on plasma renin in normal and hypertensive subjects.
Brunner HR; Baer L; Sealey JE; Ledingham JG; Laragh JH
J Clin Invest; 1970 Nov; 49(11):2128-38. PubMed ID: 4319970
[TBL] [Abstract][Full Text] [Related]
5. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
[TBL] [Abstract][Full Text] [Related]
6. The effect of spironolactone in hypertensive patients on regular haemodialysis and after renal allotransplantation.
Papadimitriou M; Vyzantiadis A; Milionis A; Memmos D; Metaxas P
Life Support Syst; 1983; 1(3):197-205. PubMed ID: 6433115
[TBL] [Abstract][Full Text] [Related]
7. Effects of sodium intake on plasma potassium and renin angiotensin aldosterone system in conscious dogs.
Kjolby MJ; Kompanowska-Jezierska E; Wamberg S; Bie P
Acta Physiol Scand; 2005 Jul; 184(3):225-34. PubMed ID: 15954990
[TBL] [Abstract][Full Text] [Related]
8. Volume independent stimulation of renin secretion by a single dose of amiloride in man.
Endemann D; Marienhagen J; Stubanus M; Luger RJ; Fischereder M; Riegger GA; Krämer BK
Arzneimittelforschung; 2002; 52(9):677-83. PubMed ID: 12404882
[TBL] [Abstract][Full Text] [Related]
9. Responses of the renal prostanoids to a short-term depletion of sodium or potassium in healthy women.
Agnoli GC; Borgatti R; Cacciari M; Garutti C; Ikonomu E; Lenzi P; Marinelli M; Stipo L
Boll Soc Ital Biol Sper; 1996; 72(3-4):109-16. PubMed ID: 8771911
[TBL] [Abstract][Full Text] [Related]
10. [Use of spironolactone and indapamide in the treatment of low-renin arterial hypertension].
Naudzhunas A; Bagdonas G; Yankauskene L; Kazanavichus G
Ter Arkh; 2006; 78(2):61-4. PubMed ID: 16613101
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension.
Mahmud A; Feely J
Am J Hypertens; 2005 Jan; 18(1):50-5. PubMed ID: 15691617
[TBL] [Abstract][Full Text] [Related]
12. [Hyporeninemic hypoaldosteronism and the differential diagnosis of hyperkalemia].
Weidmann P
Schweiz Med Wochenschr; 1982 Dec; 112(49):1764-74. PubMed ID: 6758113
[TBL] [Abstract][Full Text] [Related]
13. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
14. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
Mahmud A; Mahgoub M; Hall M; Feely J
Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
[TBL] [Abstract][Full Text] [Related]
15. [Relationship of the renin-angiotensin-aldosterone system with auricular natriuretic factor in its response to the action of thiazide diuretics and to nifedipine, a sustained-release calcium antagonist].
Ocón J; Mora-Macià J; Castellet R; del Río G
Med Clin (Barc); 1994 Jan; 102(2):41-5. PubMed ID: 8133694
[TBL] [Abstract][Full Text] [Related]
16. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
[TBL] [Abstract][Full Text] [Related]
17. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients.
Hiramatsu K; Yamada T; Yukimura Y; Komiya I; Ichikawa K; Ishihara M; Nagata H; Izumiyama T
Arch Intern Med; 1981 Nov; 141(12):1589-93. PubMed ID: 7030245
[TBL] [Abstract][Full Text] [Related]
18. [Aldosterone and magnesium].
Matsuoka H
Clin Calcium; 2005 Feb; 15(2):187-91. PubMed ID: 15692156
[TBL] [Abstract][Full Text] [Related]
19. The renin-angiotensin-aldosterone system and blood pressure during oxprenolol treatment in hypertensive patients pretreated with diuretics.
Salvetti A; Pedrinelli R; Simonini N
Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):538-42. PubMed ID: 6757151
[TBL] [Abstract][Full Text] [Related]
20. Dissociation of renin and aldosterone during low-dose epinephrine infusion.
Kruse HJ; Kreutz R; Staib S; Overlack A; Stumpe KO; Kolloch RE
Am J Hypertens; 1994 Oct; 7(10 Pt 1):913-8. PubMed ID: 7826555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
